GenomeWeb

CareDx Accuses Natera of False Advertising in Second Lawsuit

Apr 10, 2019

This article has been updated to include a statement from Natera.

NEW YORK (GenomeWeb) – CareDx has filed a second lawsuit against Natera today in the United States District Court for Delaware, accusing the company of trying to "mislead" patients and clinicians into thinking that Natera's Prospera kidney transplant test is superior to CareDx's AlloSure organ transplant diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Menu

CareDx Accuses Natera of False Advertising in Second Lawsuit

To read the full story....

Breaking News

Depression GWAS Based on Minimal Phenotyping May Lead to Skewed Results

Refractive Error GWAS Leads To More Than 300 New Loci

Bruker Releases Final Q4, Full-Year 2020 Results

Top Five Articles on GenomeWeb Last Week: COVID-19, BioMérieux, FDA, and More

Rendu Biotechnology Gets Emergency Approval in China for Coronavirus Detection Kit

Myriad Genetics Seeks Japan Approval for Advanced Pancreatic, Prostate Cancer Companion Diagnostic

The Scan

In a Different Lab

Relief Bill Signed

Little Bit Improved

PLOS Studies on Anti-Viral Epigenetic Drugs, Liver Cancer Oncogene, Brazilian HIV Diversity

What's Popular?

Rendu Biotechnology Gets Emergency Approval in China for Coronavirus Detection Kit

Bruker Releases Final Q4, Full-Year 2020 Results

Fosun Long March Gets Chinese Regulatory Approval for Coronavirus MDx Kit

GigaMune Hopes to Offer TCR Screens to Pharmas While Scrambling to Keep Expression Libraries Alive

Biocartis, Immunexpress Ink Co-Commercialization Agreement for Sepsis Test

Sponsorships